Respiratory Inhaler Devices Market: Increasing Prevalence of Asthma and COPD to drive the Global market for Respiratory Inhalers Devices; Global Industry Analysis and Opportunity Assessment, 2015 - 2025

  • Published: 2015-10-27
  • Report Code: REP-GB-493

An Incisive, In-depth Analysis on the Respiratory Inhaler Devices Market

This study offers a comprehensive, 360 degree analysis on the Respiratory Inhaler Devices market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Respiratory Inhaler Devices market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Respiratory devices are medical devices are used to assist a patient encountering breathing problems resulting from respiratory disorders such as fibrosis, asthma, COPD and ARDS and others. On the basis of product type, the market has been segmented into dry powder inhaler (DPI), metered dose inhaler (MDI) and nebuliser. Nebuliser is further sub-segmented into compressed air nebuliser, ultrasonic nebuliser and mesh nebuliser.

Market Value and Forecast

In terms of value, the global respiratory inhaler devices market is estimated to expand at a CAGR of 4.3% during the forecast period. The global respiratory inhaler devices market value is expected to increase to US$ 43,214.0 Mn by 2025 end.

Market Dynamics

Growth of the global respiratory inhaler devices market is mainly driven by rising prevalence of asthma, chronic respiratory diseases, COPD and other respiratory diseases. However, lack of a single effective inhaler devices for all type of disease indication, side effects and complications during drug inhalation, lack of skilled pulmonologist, physicians and nurses, lack of awareness, coupled with high prices of inhaler devices are factors restraining market growth.

Patients are shifting towards combined therapies due to associated benefits such as more reliable in complex patients, increased efficacy and easy reimbursement policies associated with therapy. Combination therapies cost more compared to conventional therapies for patients with complex indications of respiratory disease. Increase in usage of combination therapies such as triple combination therapy for COPD patients is expected to drive growth of the global respiratory inhaler devices market over the forecast period.

Market Segmentation By Product

On the basis of product type, the market has been segmented into dry powder inhaler, metered dose inhaler and nebuliser. In terms of value, the metered dose inhaler segment is estimated to account for over 69.9% share of the global respiratory inhaler devices market by 2015 end, and is expected to remain dominant during the forecast period.

Global Respiratory Inhaler Devices Market Value

Market Segmentation By Disease Indication

On the basis of disease indication, the market has been segmented into asthma, COPD, pulmonary arterial hypertension and other respiratory diseases. COPD is expected to be third leading cause of death and fifth leading cause of disability by 2020 end. Numerous health awareness programmes being conducted across the globe are expected to result in the COPD segment registering a higher CAGR of 4.8% over the forecast period.

Market Segmentation By Technology

On the basis of the technology, market has been segmented into manually operated inhaler devices and digitally operated inhaler devices. Digitally operated inhaler devices is expected to register a CAGR of 3.8% over the forecast period. Application of GPS and Bluetooth technology in inhaler devices is expected to drive demand for digitally operated inhaler devices over the forecast period.

Key Regions

The global respiratory inhaler devices market has been segmented into seven major regions namely North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa. In terms of value, North America is estimated to dominate the market with 40.0% share of the overall respiratory inhaler devices market by 2015 end. APEJ is estimated to be the fastest growing market, registering a CAGR of 5.0% in terms of value over the forecast period. Currently, metered dose inhaler is a major contributor in markets in Europe, North America and parts of Asia Pacific, while nebuliser segment is expected to exhibit a CAGR of 3.8% in terms of value during the forecast period.

Key Players

Some key players identified in the global respiratory inhaler devices market report include: AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd. These companies are focusing towards enhancing their product portfolio through the introduction of innovative and cost-effective products to strengthen position in the market in the long term.

Updated Version:

Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment, 2017 - 2027

Future Market Insights offers a 10-year forecast of the global respiratory inhaler devices market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 4.3% during the projected period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the respiratory inhaler devices market over the forecast period.

Report Description

This Future Market Insights report examines the respiratory inhaler devices market for the period 2015–2025. The primary objective of the report is to offer insights into developments in the respiratory inhaler devices market that are significantly transforming global businesses and enterprises. Increasing prevalence of asthma, COPD and other respiratory diseases coupled with rising awareness is predicted to increase usages of respiratory inhaler devices worldwide. This is expected to bolster growth of the respiratory inhaler devices market over the next five to six years. Increasing demand for inhalation respiratory inhaler devices for controlling asthma and other respiratory disease, especially among children and elderly population, is expected to drive growth of respiratory inhaler devices market during the forecast period. Companies are focusing on regions and sections where prevalence of asthma, and chronic lung disease are increasing such as Asia Pacific and MEA.

The respiratory inhaler devices market report begins with an overview of the respiratory inhaler devices market in terms of value. This section includes FMI analysis of key trends, drivers and restraints and opportunity, which are factors influencing growth of the respiratory inhaler devices market. Impact analysis of key growth drivers and restraints based on the weighted average model is included in the respiratory inhaler devices market report to better equip clients with crystal clear decision-making insights.

The global respiratory inhaler devices market is segmented on the basis of products type into dry powder inhaler (DPI), metered dose inhaler (MDI) and nebuliser. Nebuliser is further sub-segmented into compressed air nebuliser, ultrasonic nebuliser and mesh nebuliser. A detailed analysis has been provided for every segment and sub-segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

The next section of the report highlights respiratory inhaler devices adoption by region. It provides a market outlook for 2015–2025 and sets the forecast within the context of the respiratory inhaler devices market. The study discusses key regional trends contributing to growth of the respiratory inhaler devices market worldwide, as well as analyses the extent to which drivers are influencing this market in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and Middle East & Africa.

The above sections – by product type and region – evaluate the present scenario and growth prospects of the respiratory inhaler devices market for the period 2015 –2025. We have considered 2014 as the base year and provide data for the forecast period.

To ascertain respiratory inhaler devices market size, we have also considered revenue generated by manufacturers. The forecast presented here assesses the total revenue by value across the respiratory inhaler devices market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the respiratory inhaler devices market is expected to develop in the future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis, based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the respiratory inhaler devices market.

The respiratory inhaler devices segments in terms of product and regions are analysed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identification of various key trends in the respiratory inhaler devices market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the respiratory inhaler devices market.

To understand key growth segments in terms of growth and adoption for dry powder inhaler, metered dose inhaler and nebuliser across the globe in the near future, Future Market Insights developed the respiratory inhaler devices market ‘Attractiveness Index’. The resulting index should help providers identify real market opportunities.

In the final section of the report, respiratory inhaler devices ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of providers in the value chain of the respiratory inhaler devices product portfolio and key differentiators. Key categories of providers covered in the report are respiratory inhaler devices manufacturers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the respiratory inhaler devices value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in respiratory inhaler devices marketplace.

Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the respiratory inhaler devices market. Key competitors covered in terms of manufacturers include AstraZeneca, Beximco Pharmaceuticals Ltd., Boehringer Ingelheim GmbH, Cipla Ltd., GlaxoSmithKline plc, Koninklijke Philips N.V., Merck & Co., Inc., OMRON Healthcare Europe B.V., PARI Medical Holding and Teva Pharmaceutical Industries Ltd.

Key Segments Covered

  • Product Type
    • Dry Powder Inhaler
    • Metered Dose Inhaler
    • Nebulizer
      • Ultrasonic Nebulizer
      • Compressed Air Nebulizer
      • Mesh Nebulizer
  • By Disease Indication
    • Asthma
    • COPD
    • Pulmonary Arterial Hypertension
    • Others Respiratory Disease
  • By Technology
    • Manually Operated Inhaler Devices
    • Digitally Operated Inhaler Devices

Key Regions/Countries Covered

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Western Europe
    • EU5
    • Nordics
    • BENELUX
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Russia
    • Rest of Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
    • Greater China
    • India
    • ASEAN
    • Australia and New Zealand
    • Rest of APEJ
  • Japan
  • Middle East & Africa
    • GCC
    • South Africa
    • Israel
    • Turkey
    • Rest of MEA

Key Companies

  • AstraZeneca
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • OMRON Healthcare Europe B.V.
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

Respiratory Inhaler Devices Market Reports - Table of Contents

Respiratory Inhaler Devices Market Reports - List of Tables

Table 1: Global Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 2: Global Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 3: Global Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 4: Global Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 5: Global Respiratory Inhaler Devices Market Value Forecast By Disease Indication, 2013–2025 (US$ Mn)

Table 6: Global Respiratory Inhaler Devices Market Volume Forecast By Disease Indication, 2013–2025 (US$ Mn)

Table 7: Global Respiratory Inhaler Devices Market Value Forecast By Region, 2013–2025 (US$ Mn)

Table 8: Global Respiratory Inhaler Devices Market volume Forecast By Region, 2013–2025 (US$ Mn)

Table 9: North America Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 10: North America Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 11: North America Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 12: North America Respiratory Inhaler Devices Market Value Forecast By Disease Indication, 2013–2025 (US$ Mn)

Table 13: North America Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 14: North America Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 15: North America Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 16 : North America Respiratory Inhaler Devices Market Volume Forecast By Disease Indication, 2013–2025 (US$ Mn)

Table 17: Latin America Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 18: Latin America Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 19: Latin America Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 20: Latin America Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 21 : Latin America Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 22 : Latin America Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 23 : Latin America Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 24 : Latin America Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 25: Western Europe Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 26: Western Europe Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 27: Western Europe Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 28: Western Europe Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

 Table 29: Western Europe Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 30: Western Europe Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 31: Western Europe Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 32: Western Europe Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 33: Eastern Europe Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 34: Eastern  Europe Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 35: Eastern Europe Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 36: APEJ Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 37: Eastern Europe Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 38: Eastern Europe Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 39: Eastern  Europe Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 40: Eastern Europe Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 41: APEJ Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 42: APEJ  Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 43: APEJ Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 44: APEJ Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 45: APEJ Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 46: APEJ Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 47: APEJ Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 48: APEJ Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 49: Japan Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 50: Japan Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 51: Japan Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 52: Japan Respiratory Inhaler Devices Market Volume Forecast By Product, 2013–2025 (US$ Mn)

Table 53: Japan Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 54: Japan Respiratory Inhaler Devices Market Volume Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 55: MEA Respiratory Inhaler Devices Market Value Forecast By Country, 2013–2025 (US$ Mn)

Table 56: MEA Respiratory Inhaler Devices Market Value Forecast By Product, 2013–2025 (US$ Mn)

Table 57: MEA Respiratory Inhaler Devices Market Value Forecast By Technology, 2013–2025 (US$ Mn)

Table 58: MEA  Respiratory Inhaler Devices Market Value Forecast By Disease Indication 2013–2025 (US$ Mn)

Table 59: MEA Respiratory Inhaler Devices Market Volume Forecast By Country, 2013–2025 (US$ Mn)

Table 60: MEA Respiratory Inhaler Devices Market Volume  Forecast By Product, 2013–2025 (US$ Mn)

Table 61: MEA Respiratory Inhaler Devices Market Volume Forecast By Technology, 2013–2025 (US$ Mn)

Table 62: MEA  Respiratory Inhaler Devices Market Volume  Forecast By Disease Indication 2013–2025 (US$ Mn)

Respiratory Inhaler Devices Market Reports - List of Figures

Figure 1: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity 2013–2025

Figure 2: Global Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 3: Global Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 4: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Dry Powder Inhaler 2013–2025

Figure 5: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Metered Dose Inhaler 2013–2025

Figure 6: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Nebuliser 2013–2025

Figure 7: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Ultrasonic Nebuliser 2013–2025

Figure 8: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Compressed Air Nebuliser 2013–2025

Figure 9: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Mesh Nebuliser 2013–2025

Figure 10: Global Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 11: Global Respiratory Inhaler Devices Market Value Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 12: Global Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 13: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Manually Operated Inhaler Devices 2013–2025

Figure 14: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Digitally Operated Inhaler Devices 2013–2025

Figure 15: Global Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 16: Global Respiratory Inhaler Devices Market Value Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 17: Global Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 18: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Asthma 2013–2025

Figure 19: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By COPD 2013–2025

Figure 20: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Pulmonary Arterial Hypertension 2013–2025

Figure 21: Global Respiratory Inhaler Devices Market Value (US$ Mn) & Absolute $ Opportunity By Other Respiratory Disease 2013–2025

Figure 22: Global Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 23: Global Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 24: Global Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 25: Global Respiratory Inhaler Devices Market Attractiveness By Region, 2015–2025

Figure 26: North America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By North America Region, 2015–2025

Figure 27: North America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast North America By Product Type, 2015–2025

Figure 28: North America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 29: North America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 30: North America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 31: North America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 32: North America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 33: North America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 34: North America Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 35: North America Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 36: North America Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 37: North America Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 38: Latin America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 39: Latin America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 40: Latin America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 41: Latin America Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 42: Latin  America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 43: Latin America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 44: Latin Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 45: Latin America Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 46: Latin America Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 47: Latin America Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 48: Latin America Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 49: Latin America Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 50: Western Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 51: Western Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 52: Western Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 53: Western Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 54: Western Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 55: Western Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 56: Western Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 57: Western Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 58: Western Europe Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 59: Western Europe Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 60: Western Europe Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 61: Western Europe Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 62: Eastern Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 63: Eastern Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 64: Eastern Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 65: Eastern Europe Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 66: Eastern Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 67: Eastern Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 68: Eastern Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 69: Eastern Europe Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 70: Eastern Europe Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 71: Eastern Europe Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 72: Eastern Europe Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 73: Eastern Europe Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 74: APEJ Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 75: APEJ Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 76: APEJ Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 77: APEJ Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 78: APEJ Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 79: APEJ Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 80: APEJ Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 81: APEJ Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 82: APEJ Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 83: APEJ Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 84: APEJ Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 85: APEJ Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 86: Japan Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 87: Japan Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 88: Japan Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 89: Japan Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 90: Japan Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 91: Japan Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 92: Japan Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 93: Japan Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 94: Japan Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Figure 95: Middle East and Africa Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Region, 2015–2025

Figure 96: Middle East and Africa Respiratory Inhaler Devices Market Y-o-Y Growth Forecast By Product Type, 2015–2025

Figure 97: Middle East and Africa Respiratory Inhaler Devices Market Value Y-o-Y Growth Forecast By Technology, 2015–2025

Figure 98: Middle East and Africa Respiratory Inhaler Devices Market Value Y-o-Y Growth Forecast By Disease Indication, 2015–2025

Figure 99: Middle East and Africa Respiratory Inhaler Devices Market Value Share & BPS Analysis By Region 2015, 2020 & 2025

Figure 100: Middle East and Africa Respiratory Inhaler Devices Market Value Share & BPS Analysis By Product Type 2015, 2020 & 2025

Figure 101: Middle East and Africa Respiratory Inhaler Devices Market Value Share & BPS Analysis By Technology 2015, 2020 & 2025

Figure 102: Middle East and Africa Respiratory Inhaler Devices Market Value Share & BPS Analysis By Disease Indication 2015, 2020 & 2025

Figure 103: MEA Respiratory Inhaler Devices Market Attractiveness By Country, 2015–2025

Figure 104: MEA Respiratory Inhaler Devices Market Attractiveness By Product Type, 2015–2025

Figure 105: MEA Respiratory Inhaler Devices Market Attractiveness By Technology, 2015–2025

Figure 106: MEA Respiratory Inhaler Devices Market Attractiveness By Disease Indication, 2015–2025

Get in touch

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology